Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
decrease release » increased release (Expand Search)
greater decrease » greater increase (Expand Search), greater increases (Expand Search), rate decreased (Expand Search)
larger decrease » marked decrease (Expand Search)
Showing 21 - 40 results of 8,845 for search '(( significant decrease release ) OR ( significantly ((larger decrease) OR (greater decrease)) ))', query time: 1.45s Refine Results
  1. 21
    Positive ion mode significant differential metabolites (Fold Change greater than 2 or less than 0.5).

    Positive ion mode significant differential metabolites (Fold Change greater than 2 or less than 0.5). by Peng-fei Han (694841)

    Published 2025
    Save to List
    Saved in:
  2. 22
    Myelinopathy results in a significantly reduced spike probability and increased latency after a release event.

    Myelinopathy results in a significantly reduced spike probability and increased latency after a release event. by Maral Budak (6680351)

    Published 2021
    Save to List
    Saved in:
  3. 23
    The apparent Ca<sup>2+</sup> affinity of release is decreased by hydrophobic mutations.

    The apparent Ca<sup>2+</sup> affinity of release is decreased by hydrophobic mutations. by Matthew R. Bowers (8423115)

    Published 2020
    “…<b>B,</b> Ca<sup>2+</sup> curves normalized to maximum EJP amplitude predicted by the nonlinear regression. The significant rightward shift in the curve (EC50, non overlapping confidence intervals) indicates a decrease in the apparent Ca<sup>2+</sup> affinity of neurotransmitter release.…”
    Save to List
    Saved in:
  4. 24
    Energy efficiency variation across cities in the Greater Bay Area.

    Energy efficiency variation across cities in the Greater Bay Area. by YanFei Lei (19532983)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  5. 25
    Change in Watt’s Connectedness Scale, Subscales by Treatment Group.

    Change in Watt’s Connectedness Scale, Subscales by Treatment Group. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 26
    Primary and secondary efficacy end points (intention-to-treat population).

    Primary and secondary efficacy end points (intention-to-treat population). by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 27
    Demographic and clinical characteristics of participants at baseline.

    Demographic and clinical characteristics of participants at baseline. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 28
    Study-related adverse events.

    Study-related adverse events. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 29
    Study flow chart.

    Study flow chart. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 30
    Change in QIDS-SR-16 and MBI-HSS-MP by Treatment Group.

    Change in QIDS-SR-16 and MBI-HSS-MP by Treatment Group. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 31
    Study CONSORT diagram.

    Study CONSORT diagram. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 32
    Change in Demoralization Scale (DSII) by Treatment Group.

    Change in Demoralization Scale (DSII) by Treatment Group. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 33
    Change in Watt’s Connectedness Scale (WCS), General Connectedness by Treatment Group.

    Change in Watt’s Connectedness Scale (WCS), General Connectedness by Treatment Group. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 34
    Phase 2 significant effects.

    Phase 2 significant effects. by Wendy C. Crone (2262169)

    Published 2023
    Save to List
    Saved in:
  15. 35
    Phase 1 significant effects.

    Phase 1 significant effects. by Wendy C. Crone (2262169)

    Published 2023
    Save to List
    Saved in:
  16. 36
    The results of GO functional enrichment analysis (Annotation: The higher the value, the greater the importance).

    The results of GO functional enrichment analysis (Annotation: The higher the value, the greater the importance). by Lin Zhou (141050)

    Published 2023
    Save to List
    Saved in:
  17. 37
    Supplementary Material for: Adjunctive active vitamin D (AVD) decreases kidney function during treatment of secondary hyperparathyroidism (SHPT) with extended-release calcifediol (ERC) in non-dialysis chronic kidney disease (ND-CKD)

    Supplementary Material for: Adjunctive active vitamin D (AVD) decreases kidney function during treatment of secondary hyperparathyroidism (SHPT) with extended-release calcifediol (... by figshare admin karger (2628495)

    Published 2025
    Save to List
    Saved in:
  18. 38
    Sobel test for the significance of the mediation effect.

    Sobel test for the significance of the mediation effect. by Getachew Magnar Kitila (19935139)

    Published 2024
    Save to List
    Saved in:
  19. 39
    Decrease in METH-evoked DA release in the nucleus accumbens in <i>Ptprz</i>-KO mice.

    Decrease in METH-evoked DA release in the nucleus accumbens in <i>Ptprz</i>-KO mice. by Akihiro Fujikawa (122649)

    Published 2019
    Save to List
    Saved in:
  20. 40
    Life stages used in life cycle model [36].

    Life stages used in life cycle model [36]. by Caleb B. Fogel (12858982)

    Published 2022
    Subjects:
    Save to List
    Saved in:

Search Tools: